ONWARD® Medical and Partners Awarded Christopher & Dana Reeve Foundation Grant to Further Study Brain-Computer Interface System
03 sept. 2024 01h30 HE
|
ONWARD Medical NV
ONWARD® Medical and Partners Awarded Christopher & Dana Reeve Foundation Grant to Further Study Brain-Computer Interface System
ONWARD® Medical Schedules Webcast to Provide Half-Year 2024 Business Update
27 août 2024 12h53 HE
|
ONWARD Medical NV
ONWARD® Medical Schedules Webcast to Provide Half-Year 2024 Business Update
ONWARD® Medical Reaffirms 2024 Strategic Priorities and Releases Unaudited Q2 Financial Highlights
05 août 2024 17h47 HE
|
ONWARD Medical NV
ONWARD® Medical Reaffirms 2024 Strategic Priorities and Releases Unaudited Q2 Financial Highlights
ONWARD® Medical Publishes Annual Sustainability Summary
17 juil. 2024 01h30 HE
|
ONWARD Medical NV
ONWARD® Medical Publishes Annual Sustainability Summary
ONWARD® Medical Announces Publication Highlighting Evidence-based Programming for ARC-EX® Therapy
09 juil. 2024 13h18 HE
|
ONWARD Medical NV
ONWARD® Medical Announces Publication Highlighting Evidence-based Programming for ARC-EX® Therapy
ONWARD® Medical Obtains Debt Financing with up to €52.5 Million Secured Loan from Runway Growth Capital LLC
28 juin 2024 17h53 HE
|
ONWARD Medical NV
THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE (7)(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) Runway Growth Capital LLC is a leading U.S.-based specialty...
ONWARD® Medical Announces Participation in Stifel European Healthcare Summit
26 juin 2024 01h30 HE
|
ONWARD Medical NV
ONWARD® Medical Announces Participation in Stifel European Healthcare Summit
ONWARD® Medical to Highlight Brain-Computer Interface at HLTH Europe Conference
18 juin 2024 01h30 HE
|
ONWARD Medical NV
ONWARD® Medical to Highlight Brain-Computer Interface at HLTH Europe Conference
ONWARD® Medical Announces Results of Annual General Meeting of Shareholders
13 juin 2024 17h36 HE
|
ONWARD Medical NV
ONWARD® Medical Announces Results of Annual General Meeting of Shareholders: shareholders approve all proposed resolutions
ONWARD® Medical fait le point sur le premier trimestre 2024 et sur les faits marquants de l’année écoulée
23 mai 2024 21h19 HE
|
ONWARD Medical NV
La revue Nature Medicine a publié les résultats de l’essai clinique pivot Up-LIFT Dépôt auprès de la FDA d’une demande de classification du dispositif ARC-EX® System basée sur les risques (demande...